Ryman Healthcare enjoyed its best week in almost two years.
The NZX-listed medicinal cannabis firm went into voluntary administration late last month.
And some market participants question Sharesies’ role in promoting the offer.
Regulatory approval for its purchase of Challenger Bank is dependent on the $210m equity raise.
Gas field’s 46% owner Genesis announces ‘wireline intervention campaign’ after new well produces less than expected.
AI-focused company’s stock is up 350% in just three days since reverse listing.
Retirement village operator says it has been cashflow neutral since November through higher sales and lower development activity.
Bevan McKenzie to leave the company in October after seven years in the role.
Shares in new backdoor listing Being AI jump 194% prompting please explain from NZ RegCo.
The acquisition is subject to New Zealand regulatory approvals.
